KU Hematology & Medical Oncology Review 2019

 

KU Hematology & Medical Oncology Review 2019
W

Anti-PD-1 Therapy and Dose Modification in Advanced Gastroesophageal Cancers: How Much Do We Know?

By KU Hematology & Medical Oncology Review 2019 FEATURING Weijing Sun
By KU Hematology & Medical Oncology Review 2019 FEATURING Weijing Sun
313 views
August 23, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss
Gastrointestinal
14:39

KU ASCO 2019 Updates on Pancreatic Cancer: Maintenance Olaparib and …

KU Hematology & Medical Oncology Review 2019

R. Al-Rajabi

846 views
16:20

KU ASCO 2019 Updates on Hepatobiliary Cancer: Pembrolizumab vs. Best…

KU Hematology & Medical Oncology Review 2019

R. Al-Rajabi

422 views
19:12

Management of Toxicities in Neoadjuvant (Perioperative) Chemotherapy…

KU Hematology & Medical Oncology Review 2019

W. Sun

244 views
18:29

Anti-PD-1 Therapy and Dose Modification in Advanced Gastroesophageal…

KU Hematology & Medical Oncology Review 2019

W. Sun

313 views